IMMUNIC, INC. Files 8-K: Director Changes & Officer Compensation Updates
Ticker: IMUX · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-compensation, board-changes
TL;DR
IMMUNIC board shakeup and exec pay changes filed today.
AI Summary
On June 4, 2025, IMMUNIC, INC. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of new directors, and updates to compensatory arrangements for certain officers. Additionally, the filing covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directorship and officer compensation can indicate internal restructuring or strategic realignments that may carry inherent risks.
Key Players & Entities
- IMMUNIC, INC. (company) — Registrant
- June 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1200 Avenue of the Americas, Suite 200 New York, NY 10036 (address) — Principal business address
FAQ
Who has departed from IMMUNIC, INC.'s board of directors?
The filing indicates the departure of a director, but the specific name is not provided in the provided text.
What are the key items reported in the 8-K filing dated June 4, 2025?
The filing reports on the departure of directors, election of directors, appointment of officers, compensatory arrangements, submission of matters to a vote of security holders, and financial statements/exhibits.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated June 4, 2025.
What is IMMUNIC, INC.'s state of incorporation and IRS Employer Identification Number?
IMMUNIC, INC. is incorporated in Delaware and has an IRS Employer Identification No. of 56-2358443.
What is the primary business address of IMMUNIC, INC.?
The primary business address is 1200 Avenue of the Americas, Suite 200, New York, NY 10036.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding IMMUNIC, INC. (IMUX).